127
Views
0
CrossRef citations to date
0
Altmetric
Other

Positive feedback loop between vision-related anxiety and self-reported visual difficulty

ORCID Icon, , , , , , & show all
Pages 327-333 | Received 12 Dec 2022, Accepted 24 Apr 2023, Published online: 04 May 2023

References

  • Georgiou M, Fujinami K, Michaelides M. Inherited retinal diseases: therapeutics, clinical trials and end points-A review. Clin Exp Ophthalmol. 2021 Apr;49(3):270–88. doi:10.1111/ceo.13917. Epub 2021 Mar 20. PMID: 33686777.
  • Sahel JA, Marazova K, Audo I. Clinical characteristics and current therapies for inherited retinal degenerations. Cold Spring Harb Perspect Med. 2014 Oct 16;5(2):a017111. doi:10.1101/cshperspect.a017111. PMID: 25324231; PMCID: PMC4315917.
  • Assi L, Chamseddine F, Ibrahim P, Sabbagh H, Rosman L, Congdon N, Evans J, Ramke J, Kuper H, Burton MJ, et al. A global assessment of eye health and quality of life: a systematic review of systematic reviews. JAMA Ophthalmol. 2021 May 1;139(5):526–41. doi:10.1001/jamaophthalmol.2021.0146. PMID: 33576772; PMCID: PMC7881366.
  • Kempen GI, Ballemans J, Ranchor AV, van Rens GH, Zijlstra GA. The impact of low vision on activities of daily living, symptoms of depression, feelings of anxiety and social support in community-living older adults seeking vision rehabilitation services. Qual Life Res. 2012 Oct;21(8):1405–11. doi:10.1007/s11136-011-0061-y. Epub 2011 Nov 17. Erratum in: Qual Life Res. 2012 Oct;21(8):1413. PMID: 22090173; PMCID: PMC3438403.
  • Shah K, Frank CR, Ehrlich JR. The association between vision impairment and social participation in community-dwelling adults: a systematic review. Eye (Lond). 2020 Feb;34(2):290–8. doi:10.1038/s41433-019-0712-8. Epub 2020 Jan 2. PMID: 31896798; PMCID: PMC7002691.
  • Lundeen EA, Saydah S, Ehrlich JR, Saaddine J. Self-reported vision impairment and psychological distress in U.S. adults. Ophthalmic Epidemiol. 2022 Apr;29(2):171–81. doi:10.1080/09286586.2021.1918177. Epub 2021 Apr 26. PMID: 33896341.
  • Mangione CM, Berry S, Spritzer K, Janz NK, Klein R, Owsley C, Lee PP. Identifying the content area for the 51-item national eye institute visual function questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol. 1998 Feb;116(2):227–33. doi:10.1001/archopht.116.2.227. PMID: 9488276.
  • Lamoureux EL, Pallant JF, Pesudovs K, Rees G, Hassell JB, Keeffe JE. The impact of vision impairment questionnaire: an assessment of its domain structure using confirmatory factor analysis and rasch analysis. Investig Ophthalmol Vis Sci. 2007 Mar;48(3):1001–6. doi:10.1167/iovs.06-0361. PMID: 17325138.
  • Lacy GD, Abalem MF, Popova LT, Santos EP, Yu G, Rakine HY, Rosenthal JM, Ehrlich JR, Musch DC, Jayasundera KT. Content generation for patient-reported outcome measures for retinal degeneration therapeutic trials. Ophthalmic Genet. 2020 Aug;41(4):315–24. doi:10.1080/13816810.2020.1776337. Epub 2020 Jun 22. PMID: 32571121; PMCID: PMC7503769.
  • Goldstein JE, Chun MW, Fletcher DC, Deremeik JT, Massof RW, Low Vision Research Network Study Group. Visual ability of patients seeking outpatient low vision services in the United States. JAMA Ophthalmol. 2014 Oct;132(10): 1169–77. doi:10.1001/jamaophthalmol.2014.1747. PMID: 25073745; PMCID: PMC6746572.
  • Ustün B, Kennedy C. What is “functional impairment”? Disentangling disability from clinical significance. World Psychiatry. 2009 Jun;8(2):82–5. doi:10.1002/j.2051-5545.2009.tb00219.x. PMID: 19516924; PMCID: PMC2691163.
  • Margolis MK, Coyne K, Kennedy-Martin T, Baker T, Schein O, Revicki DA. Vision-specific instruments for the assessment of health-related quality of life and visual functioning: a literature review. Pharmacoeconomics. 2002;20(12):791–812. doi:10.2165/00019053-200220120-00001. PMID: 12236802.
  • Owsley C, McGwin G Jr. Bidirectionality of the association of vision impairment with depression and anxiety. JAMA Ophthalmol. 2019 Jul 1;137(7):801. doi:10.1001/jamaophthalmol.2019.1084. PMID: 31095254.
  • Fedak KM, Bernal A, Capshaw ZA, Gross S. Applying the Bradford Hill criteria in the 21st century: how data integration has changed causal inference in molecular epidemiology. Emerg Themes Epidemiol. 2015 Sep 30;12:(1):14. doi:10.1186/s12982-015-0037-4. PMID: 26425136; PMCID: PMC4589117.
  • Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965 May;58(5):295–300. doi:10.1177/003591576505800503. PMID: 14283879; PMCID: PMC1898525.
  • Frank CR, Xiang X, Stagg BC, Ehrlich JR. Longitudinal associations of self-reported vision impairment with symptoms of anxiety and depression among older adults in the United States. JAMA Ophthalmol. 2019;137(7):793–800. doi:10.1001/jamaophthalmol.2019.1085.
  • Heesterbeek TJ, van der Aa HPA, van Rens GHMB, Twisk JWR, van Nispen RMA. The incidence and predictors of depressive and anxiety symptoms in older adults with vision impairment: a longitudinal prospective cohort study. Ophthalmic Physiol Opt. 2017 Jul;37(4):385–98. doi:10.1111/opo.12388. Epub 2017 May 18. PMID: 28516509.
  • Kempen GI, Zijlstra GA. Clinically relevant symptoms of anxiety and depression in low-vision community-living older adults. Am J Geriatr Psychiatry. 2014 Mar;22(3):309–13. doi:10.1016/j.jagp.2012.08.007. Epub 2013 Jan 16. PMID: 23567435.
  • van der Aa HP, Comijs HC, Penninx BW, van Rens GH, van Nispen RM. Major depressive and anxiety disorders in visually impaired older adults. Investig Ophthalmol Vis Sci. 2015 Jan 20;56(2):849–54. doi:10.1167/iovs.14-15848. PMID: 25604690.
  • Akuffo KO, Sewpaul R, Darrah S, Dukhi N, Kumah DB, Agyei-Manu E, Addo EK, Asare AK, Osei Duah I Jr, Reddy P. Vision loss, vision difficulty and psychological distress in South Africa: results from SANHANES-1. BMC Psychol. 2021 Apr 29;9(1):66. doi:10.1186/s40359-021-00558-x. PMID: 33926560; PMCID: PMC8082762.
  • Caballe-Fontanet D, Alvarez-Peregrina C, Busquet-Duran N, Pedemonte-Sarrias E, Andreu-Vázquez C, Sánchez-Tena MÁ. Quality of life and anxiety in age macular degeneration patients: a cross-sectional study. Int J Environ Res Public Health. 2022 Jan 12;19(2):820. doi:10.3390/ijerph19020820. PMID: 35055640; PMCID: PMC8776064.
  • Wu N, Kong X, Sun X. Anxiety and depression in Chinese patients with glaucoma and its correlations with vision-related quality of life and visual function indices: a cross-sectional study. BMJ Open. 2022 Feb 21;12:(2):e046194. doi:10.1136/bmjopen-2020-046194. PMID: 35190403; PMCID: PMC8860023.
  • Senra H, Hernandez-Moreno L, Moreno N, Macedo AF. Anxiety levels moderate the association between visual acuity and health-related quality of life in chronic eye disease patients. Sci Rep. 2022 Feb 10;12(1):2313. doi:10.1038/s41598-022-06252-1. PMID: 35145163; PMCID: PMC8831583.
  • Popova LT, Abuzaitoun RO, Abalem MF, Andrews CA, Mondul AM, Lacy GD, Musch DC, Jayasundera KT. Effects of duration and number of symptoms on vision-related anxiety in patients with inherited retinal diseases. Ophthalmic Genet. 2022 Nov;28(1):1–8. doi:10.1080/13816810.2022.2144901. Epub ahead of print. PMID: 36440767.
  • Sekimitsu S, Shweikh Y, Zebardast N. Effect of visual impairment on depression and anxiety during the COVID-19 pandemic in the United States. Can J Ophthalmol. 2022 Dec 1;S0008-4182(22): 00369-6. doi:10.1016/j.jcjo.2022.11.019. Epub ahead of print. PMID: 36529268; PMCID: PMC9712066.
  • McEwen BS. Neurobiological and systemic effects of chronic stress. Chronic stress (Thousand Oaks). 2017 Jan–Dec;1:2470547017692328. doi:10.1177/2470547017692328.
  • McEwen BS, Gianaros PJ. Stress- and allostasis-induced brain plasticity. Annu Rev Med. 2011;62:431–45. doi:10.1146/annurev-med-052209-100430. PMID: 20707675; PMCID: PMC4251716.
  • Guidi J, Lucente M, Sonino N, Fava GA. Allostatic load and its impact on health: a systematic review. Psychother Psychosom. 2021;90(1):11–27. doi:10.1159/000510696. Epub 2020 Aug 14. PMID: 32799204.
  • Mennin DS, Fresco DM. What, me worry and ruminate about DSM-5 and RDoC? the importance of targeting negative self-referential processing. Clin Psychol. 2013;20(3):258–67. doi:10.1111/cpsp.12038.
  • Ottaviani C, Thayer JF, Verkuil B, Lonigro A, Medea B, Couyoumdjian A, Brosschot JF. Physiological concomitants of perseverative cognition: a systematic review and meta-analysis. Psychol Bull. 2015;142(3):231–59. doi:10.1037/bul0000036.
  • Clancy F, Prestwich A, Caperon L, O’Connor DB. Perseverative cognition and health behaviors: a systematic review and meta-analysis. Front Hum Neurosci. 2016;10:534. doi:10.3389/fnhum.2016.00534.
  • DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101–7. doi:10.1001/archinte.160.14.2101.
  • Sims M, Diez-Roux AV, Gebreab SY, Brenner A, Dubbert P, Wyatt S, Bruce M, Hickson D, Payne T, Taylor H. Perceived discrimination is associated with health behaviours among African-Americans in the Jackson heart study. J Epidemiol Community Health. 2016 Feb;70(2):187–94. doi:10.1136/jech-2015-206390.
  • Jackson JS, Knight KM, Rafferty JA. Race and unhealthy behaviors: chronic stress, the HPA axis, and physical and mental health disparities over the life course. Am J Public Health. 2010 May;100(5):933–9. doi:10.2105/AJPH.2008.143446.
  • Stringham J, Ashkenazy N, Galor A, Wellik SR. Barriers to Glaucoma medication compliance among veterans: dry eye symptoms and anxiety disorders. Eye Contact Lens. 2018 Jan;44(1):50–4. doi:10.1097/ICL.0000000000000301. PMID: 28181960; PMCID: PMC5500464.
  • Lim MC, Watnik MR, Imson KR, Porter SM, Granier AM. Adherence to glaucoma medication: the effect of interventions and association with personality type. J Glaucoma. 2013 Aug;22(6):439–46. doi:10.1097/IJG.0b013e31824cd0ae. PMID: 22411021.
  • Salman M, Andrews C, Heisler M, Darnley-Fisch D, Newman-Casey PA. Psychosocial predictors of glaucoma medication adherence among the support, educate, empower (SEE) personalized glaucoma coaching pilot study participants. Am J Ophthalmol. 2020 Aug;216:207–18. doi:10.1016/j.ajo.2020.02.009. Epub 2020 Feb 19. PMID: 32087145; PMCID: PMC7434652.
  • Kong XM, Zhu WQ, Hong JX, Sun XH. Is glaucoma comprehension associated with psychological disturbance and vision-related quality of life for patients with glaucoma? A cross-sectional study. BMJ Open. 2014 May 26;4:(5):e004632. doi:10.1136/bmjopen-2013-004632. PMID: 24861547; PMCID: PMC4039808.
  • McGrady A, McGinnis R, Badenhop D, Bentle M, Rajput M. Effects of depression and anxiety on adherence to cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2009 Nov-Dec;29(6):358–64. doi:10.1097/HCR.0b013e3181be7a8f. PMID: 19940639.
  • Robinson M, Bulcourf B, Atchison JW, Berger J, Lafayette-Lucy A, Hirsh AT, Riley JL. Compliance in pain rehabilitation: patient and provider perspectives. Pain Medicine. 2004 Mar;5(1):66–80. doi:10.1111/j.1526-4637.2004.04002.x.
  • Jack K, McLean SM, Moffett JK, Gardiner E. Barriers to treatment adherence in physiotherapy outpatient clinics: a systematic review. Man Ther. 2010 Jun;15(3):220–8. doi:10.1016/j.math.2009.12.004. Epub 2010 Feb 16. PMID: 20163979; PMCID: PMC2923776.
  • Hendriks SM, Spijker J, Licht CM, Hardeveld F, de Graaf R, Batelaan NM, Penninx BW, Beekman AT. Long-term disability in anxiety disorders. BMC Psychiatry. 2016 Jul 19;16:(1):248. doi:10.1186/s12888-016-0946-y. PMID: 27431392; PMCID: PMC4950589.
  • Cosh S, von Hanno T, Helmer C, Bertelsen G, Delcourt C, Schirmer H, SENSE-Cog Group. The association amongst visual, hearing, and dual sensory loss with depression and anxiety over 6 years: the Tromsø study. Int J Geriatr Psychiatry. 2018 Apr;33(4): 598–605. doi:10.1002/gps.4827. Epub 2017 Nov 28. PMID: 29193338.
  • Brenes GA, Guralnik JM, Williamson JD, Fried LP, Simpson C, Simonsick EM, Penninx BW. The influence of anxiety on the progression of disability. J Am Geriatr Soc. 2005 Jan;53(1):34–9. doi:10.1111/j.1532-5415.2005.53007.x. PMID: 15667373; PMCID: PMC1343490.
  • Carrière I, Delcourt C, Daien V, Pérès K, Féart C, Berr C, Ancelin ML, Ritchie K. A prospective study of the bi-directional association between vision loss and depression in the elderly. J Affect Disord. 2013 Oct;151(1):164–70. doi:10.1016/j.jad.2013.05.071. Epub 2013 Jun 17. PMID: 23787409.
  • Nollett C, Ryan B, Bray N, Bunce C, Casten R, Edwards RT, Gillespie D, Smith DJ, Stanford M, Margrain TH. Depressive symptoms in people with vision impairment: a cross-sectional study to identify who is most at risk. BMJ Open. 2019 Jan 17;9:(1):e026163. doi:10.1136/bmjopen-2018-026163. PMID: 30782756; PMCID: PMC6340416.
  • Rees G, Tee HW, Marella M, Fenwick E, Dirani M, Lamoureux EL. Vision-specific distress and depressive symptoms in people with vision impairment. Investig Ophthalmol Vis Sci. 2010 Jun;51(6):2891–6. doi:10.1167/iovs.09-5080. Epub 2010 Feb 17. PMID: 20164466.
  • Shmuely-Dulitzki Y, Rovner BW, Zisselman P. The impact of depression on functioning in elderly patients with low vision. Am J Geriatr Psychiatry. 1995 Autumn;3(4):325–9. doi:10.1097/00019442-199503040-00007. Epub 2012 Sep 27. PMID: 28531066.
  • Horowitz A, Reinhardt JP, Boerner K. The effect of rehabilitation on depression among visually disabled older adults. Aging Ment Health. 2005 Nov;9(6):563–70. doi:10.1080/13607860500193500. PMID: 16214704.
  • van der Aa HP, van Rens GH, Comijs HC, Margrain TH, Gallindo-Garre F, Twisk JW, van Nispen RM. Stepped care for depression and anxiety in visually impaired older adults: multicentre randomised controlled trial. BMJ. 2015 Nov 23;351:h6127. doi:10.1136/bmj.h6127. Erratum in: BMJ. 2016;353:i1995. PMID: 26597263; PMCID: PMC4655616.
  • van Nispen RM, Virgili G, Hoeben M, Langelaan M, Klevering J, Keunen JE, van Rens GH. Low vision rehabilitation for better quality of life in visually impaired adults. Cochrane Database Syst Rev. 2020 Jan 27;1(1): CD006543 PMID: 31985055; PMCID: PMC6984642. doi:10.1002/14651858.CD006543.pub2.
  • Horowitz A, Brennan M, Reinhardt JP, MacMillan T. The impact of assistive device use on disability and depression among older adults with age-related vision impairments. J Gerontol. 2006 Sept;61(5):S274–80. doi:10.1093/geronb/61.5.S274.
  • Swamy BN, Chia EM, Wang JJ, Rochtchina E, Mitchell P. Correlation between vision- and health-related quality of life scores. Acta Ophthalmol. 2009 May;87(3):335–9. doi:10.1111/j.1755-3768.2008.01203.x. Epub 2008 Oct 7. PMID: 18937810.
  • Tseng YC, Liu SH, Lou MF, Huang GS. Quality of life in older adults with sensory impairments: a systematic review. Qual Life Res. 2018 Aug;27(8):1957–71. doi:10.1007/s11136-018-1799-2. Epub 2018 Feb 5. PMID: 29404924.
  • Diniz-Filho A, Abe RY, Cho HJ, Baig S, Gracitelli CP, Medeiros FA. Fast visual field progression is associated with depressive symptoms in patients with glaucoma. Ophthalmology. 2016;123(4):754–9. doi:10.1016/j.ophtha.2015.12.014.
  • Blanco C, Rubio J, Wall M, Wang S, Jiu CJ, Kendler KS. Risk factors for anxiety disorders: common and specific effects in a national sample. Depress Anxiety. 2014 Sep;31(9):756–64. doi:10.1002/da.22247. Epub 2014 Feb 27. PMID: 24577934; PMCID: PMC4147018.
  • Hyon JY, Yang HK, Han SB. Association between dry eye disease and psychological stress among paramedical workers in Korea. Sci Rep. 2019 Mar 7;9(1):3783. doi:10.1038/s41598-019-40539-0. PMID: 30846779; PMCID: PMC6405835.
  • Bitar MS, Olson DJ, Li M, Davis RM. The correlation between dry eyes, anxiety and depression: the sicca, anxiety and depression study. Cornea. 2019 Jun;38(6):684–9. doi:10.1097/ICO.0000000000001932. PMID: 30950896.
  • Genovese G, Meduri A, Muscatello MRA, Gangemi S, Cedro C, Bruno A, Aragona P, Pandolfo G. Central serous chorioretinopathy and personality characteristics: a systematic review of scientific evidence over the last 10 years (2010 to 2020). Medicina (Kaunas). 2021 Jun 16;57(6):628. doi:10.3390/medicina57060628. PMID: 34208694; PMCID: PMC8235071.
  • Wang M, Milic M, Gericke A, Mercieca K, Liu H, Ruan Y, Jiang S, van Beers T, von Pein HD, Müller MB, et al. Chronic social defeat stress causes retinal vascular dysfunction. Exp Eye Res. 2021 Dec;213:108853. doi:10.1016/j.exer.2021.108853. Epub 2021 Nov 18. PMID: 34800481.
  • Garip G, Kamal A. Systematic review and meta-synthesis of coping with retinitis pigmentosa: implications for improving quality of life. BMC Ophthalmol. 2019 Aug 13;19(1):181. doi:10.1186/s12886-019-1169-z. PMID: 31409325; PMCID: PMC6693213.
  • D’Amanda CS, Nolen R, Huryn LA, Turriff A. Psychosocial impacts of Mendelian eye conditions: a systematic literature review. Surv Ophthalmol. 2020 Sep–Oct;65(5):562–80. doi:10.1016/j.survophthal.2020.02.002. Epub 2020 Feb 12. PMID: 32059951.
  • Ulhaq ZS, Soraya GV, Dewi NA, Wulandari LR. The prevalence of anxiety symptoms and disorders among ophthalmic disease patients. Ther Adv Ophthalmol. 2022 Apr 19;14:25158414221090100. doi:10.1177/25158414221090100. PMID: 35464342; PMCID: PMC9021519.
  • van der Aa HPA, Comijs HC, Penninx BWJH, van Rens GHMB, van Nispen RMA. Major depressive and anxiety disorders in visually impaired older adults. Investig Ophthalmol Vis Sci. 2015;56(2):849–54. doi:10.1167/iovs.14-15848.
  • Lam BL, Christ SL, Lee DJ, Zheng DD, Arheart KL. Reported visual impairment and risk of suicide: the 1986-1996 national health interview surveys. Arch Ophthalmol. 2008;126(7):975–80. doi:10.1001/archopht.126.7.975.
  • van der Aa HP, Margrain TH, van Rens GH, Heymans MW, van Nispen RM. Psychosocial interventions to improve mental health in adults with vision impairment: systematic review and meta-analysis. Ophthalmic Physiol Opt. 2016 Sep;36(5):584–606. doi:10.1111/opo.12313. PMID: 27580757.
  • Office of Disease Prevention and Health Promotion, Office of the Assistant Secretary for Health. Increase the use of vision rehab services by people with vision loss — V‑08. U.S. Department of Health and Human Services, National Institutes of Health. [accessed 2022 Dec 1]. https://health.gov/healthypeople/objectives-and-data/browse-objectives/sensory-or-communication-disorders/increase-use-vision-rehab-services-people-vision-loss-v-08.
  • Goldstein JE, Massof RW, Deremeik JT, Braudway S, Jackson ML, Kehler KB, Primo SA, Sunness JS, Low Vision Research Network Study Group. Baseline traits of low vision patients served by private outpatient clinical centers in the United States. Arch Ophthalmol. 2012 Aug;130(8): 1028–37. doi:10.1001/archophthalmol.2012.1197. PMID: 22893074; PMCID: PMC6739234.
  • Owsley C, McGwin G Jr, Lee PP, Wasserman N, Searcey K. Characteristics of low-vision rehabilitation services in the United States. Arch Ophthalmol. 2009 May;127(5):681–9. doi:10.1001/archophthalmol.2009.55. PMID: 19433720; PMCID: PMC2737181.
  • Choi S, Stagg BC, Ehrlich JR. Disparities in low-vision device use among older US medicare recipients. JAMA Ophthalmol. 2018 Dec 1;136(12):1399–403. doi:10.1001/jamaophthalmol.2018.3892. Erratum in: JAMA Ophthalmol. 2018 Dec 1;136(12):1432. PMID: 30193379; PMCID: PMC6547628.
  • Guo X, Boland MV, Swenor BK, Goldstein JE. Low vision rehabilitation service utilization before and after implementation of a clinical decision support system in ophthalmology. JAMA Netw Open. 2023 Feb 1;6(2):e2254006. doi:10.1001/jamanetworkopen.2022.54006. PMID: 36735257; PMCID: PMC9898817.
  • Nuzbrokh Y, Ragi SD, Tsang SH. Gene therapy for inherited retinal diseases. Ann Transl Med. 2021 Aug;9(15):1278. doi:10.21037/atm-20-4726. PMID: 34532415; PMCID: PMC8421966.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.